Kwee Hyun Suh

This inventor holds 25 USPTO granted patents and 16 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd., Hanmi Holdings Co., Ltd.. Active years: 2007-2025.

USPTO Granted Patents = 25 (Patent Applications = 16)

% Patents Active = 68.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Icheon-si, KR (2007)
Suwon-si, KR (2009 - 2019)
Hwaseong-si, KR (2019 - 2023)

Company Filing History:

19 out of 148

Hanmi Pharm. Co., Ltd.

patents

5 out of 63

Hanmi Science Co., Ltd.

patents

1 out of 12

Hanmi Holdings Co., Ltd.

patents

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Pyrimidine Compounds

Pharmaceutical Compositions

Cancer Treatment

Protein Kinase Inhibition

Thienopyrimidine Derivatives

Tyrosine Kinase Activity

Isoquinoline Derivatives

Crystalline Forms

Clopidogrel Preparation

Azithromycin Process

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325698 - Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same (2025-06-10),

2. 11649246 - Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereof (2023-05-16),

3. 11492357 - Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinase (2022-11-08),

4. 11292786 - Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same (2022-04-05),

5. 10870639 - Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same (2020-12-22),

6. 10519141 - Pyrimidine compound and pharmaceutical use thereof (2019-12-31),

7. 10392403 - Process for preparing thienopyrimidine compound and intermediates used therein (2019-08-27),

8. RE47451 - Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases (2019-06-24),

9. 10280154 - Pyrimidine compound and pharmaceutical use thereof (2019-05-07),

10. 10160770 - Method for preparing thienopyrimidine compound and intermediates used therein (2018-12-25),

11. 10040801 - Method for preparing thienopyrimidine compound and intermediates used therein (2018-08-07),

12. 9828366 - Bicyclic derivatives and pharmaceutical composition including the same (2017-11-28),

13. RE46511 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity (2017-08-14),

14. 9388165 - Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase (2016-07-12),

15. 9345719 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity (2016-05-24),

Title: The Innovative Journey of Inventor Kwee Hyun Suh

Introduction:

Kwee Hyun Suh, a talented inventor hailing from Suwon-si, South Korea, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Kwee Hyun Suh's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

With a career spanning over two decades, Kwee Hyun Suh has established himself as a pioneer in the tech industry, with a keen focus on developing solutions that address pressing global challenges.

Collaborations:

Throughout his career, Kwee Hyun Suh has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, fostering a culture of innovation and knowledge-sharing.

Conclusion:

Inventor Kwee Hyun Suh's relentless passion for innovation, coupled with his dedication to creating a positive impact on society, solidifies his position as a visionary in the world of technology.